As of Feb 27
| +0.14 / +0.20%|
The 18 analysts offering 12-month price forecasts for Eli Lilly and Co have a median target of 74.00, with a high estimate of 87.00 and a low estimate of 65.00. The median estimate represents a +5.46% increase from the last price of 70.17.
The current consensus among 22 polled investment analysts is to Hold stock in Eli Lilly and Co. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.